Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by Christopher Sejersted Bodtker, Director. Insider active across 1 company, notably THERACLION. In total, 1 filings have been published. Activity tracked since 4 June 2021. The latest transaction was disclosed on 4 June 2021 (Conversion). Regulator: AMF. The full history is free.
1 of 1 declaration
Christopher Sejersted Bodtker is a Board Member at Theraclion. In this role, he contributes to strategic decisions and governance of the company. His expertise in the healthcare sector allows him to provide valuable insights to the board. He is involved in performance assessment and monitoring of growth initiatives.